{"title":"A systematic review of diffusion microstructure imaging (DMI): Current and future applications in neurology research","authors":"Sadegh Ghaderi , Sana Mohammadi , Farzad Fatehi","doi":"10.1016/j.dscb.2025.100238","DOIUrl":null,"url":null,"abstract":"<div><div>Diffusion Microstructure Imaging (DMI) has emerged as a transformative neuroimaging technique that offers unprecedented insights into brain tissue microstructure by disentangling contributions from the volumes of the intra-axonal (V-intra), extra-axonal (V-extra), and free-fluid (V-CSF) compartments. We aimed to systematically review the current applications and future directions of the DMI for neurology research. Following the PRISMA 2020 guidelines, PubMed, Scopus, Web of Science, and Embase were searched for articles published up to May 2025. Our review synthesized narratively, DMI’s applications in neurology, and evaluated its diagnostic and prognostic potential across neurological disorders. Twenty-one studies were included. Across various studies on tumors, neurodegeneration, stroke, aging, hydrocephalus, epilepsy, and pain, DMI consistently identified microstructural alterations that could not be detected by conventional diffusion tensor imaging and diffusion kurtosis imaging. In brain tumors, the DMI demonstrated high diagnostic accuracy by distinguishing lymphoma from glioblastoma and characterizing peritumoral infiltration in glioblastoma compared to metastases. In Parkinsonian syndromes, elevated free-water fractions in the basal ganglia and cerebellopontine tracts were strongly correlated with clinical severity and enabled subtype differentiation. In cases of acute stroke and COVID-19, DMI metrics provided more sensitive mapping of cytotoxic and vasogenic edema than the Apparent Diffusion Coefficient. Normative aging studies revealed distinct patterns of tract-specific maturation and senescence. Furthermore, applications in idiopathic normal pressure hydrocephalus, epilepsy, and migraine showed DMI’s capability to detect fluid accumulation, axonal loss, and the integrity of nociceptive pathways, respectively. This review underscores that DMI demonstrates superior sensitivity compared to conventional diffusion techniques.</div></div>","PeriodicalId":72447,"journal":{"name":"Brain disorders (Amsterdam, Netherlands)","volume":"19 ","pages":"Article 100238"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain disorders (Amsterdam, Netherlands)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666459325000587","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Diffusion Microstructure Imaging (DMI) has emerged as a transformative neuroimaging technique that offers unprecedented insights into brain tissue microstructure by disentangling contributions from the volumes of the intra-axonal (V-intra), extra-axonal (V-extra), and free-fluid (V-CSF) compartments. We aimed to systematically review the current applications and future directions of the DMI for neurology research. Following the PRISMA 2020 guidelines, PubMed, Scopus, Web of Science, and Embase were searched for articles published up to May 2025. Our review synthesized narratively, DMI’s applications in neurology, and evaluated its diagnostic and prognostic potential across neurological disorders. Twenty-one studies were included. Across various studies on tumors, neurodegeneration, stroke, aging, hydrocephalus, epilepsy, and pain, DMI consistently identified microstructural alterations that could not be detected by conventional diffusion tensor imaging and diffusion kurtosis imaging. In brain tumors, the DMI demonstrated high diagnostic accuracy by distinguishing lymphoma from glioblastoma and characterizing peritumoral infiltration in glioblastoma compared to metastases. In Parkinsonian syndromes, elevated free-water fractions in the basal ganglia and cerebellopontine tracts were strongly correlated with clinical severity and enabled subtype differentiation. In cases of acute stroke and COVID-19, DMI metrics provided more sensitive mapping of cytotoxic and vasogenic edema than the Apparent Diffusion Coefficient. Normative aging studies revealed distinct patterns of tract-specific maturation and senescence. Furthermore, applications in idiopathic normal pressure hydrocephalus, epilepsy, and migraine showed DMI’s capability to detect fluid accumulation, axonal loss, and the integrity of nociceptive pathways, respectively. This review underscores that DMI demonstrates superior sensitivity compared to conventional diffusion techniques.
扩散微结构成像(DMI)是一种革命性的神经成像技术,通过分离轴突内(V-intra)、轴突外(V-extra)和自由流体(V-CSF)区室的体积,提供了前所未有的脑组织微结构洞察。我们旨在系统地综述DMI在神经学研究中的应用现状和未来发展方向。根据PRISMA 2020指南,检索了PubMed、Scopus、Web of Science和Embase,检索了截至2025年5月发表的文章。本文综述了DMI在神经病学中的应用,并评估了其在神经系统疾病中的诊断和预后潜力。纳入了21项研究。在对肿瘤、神经退行性变、中风、衰老、脑积水、癫痫和疼痛的各种研究中,DMI一致地发现了传统弥散张量成像和弥散峰度成像无法检测到的微结构改变。在脑肿瘤中,DMI在区分淋巴瘤和胶质母细胞瘤以及胶质母细胞瘤与转移瘤的肿瘤周围浸润特征方面表现出很高的诊断准确性。在帕金森综合征中,基底神经节和桥小脑束中游离水含量的升高与临床严重程度和亚型分化密切相关。在急性卒中和COVID-19病例中,DMI指标提供了比表观弥散系数更敏感的细胞毒性和血管源性水肿制图。规范的衰老研究揭示了不同的模式的管道特异性成熟和衰老。此外,在特发性常压脑积水、癫痫和偏头痛中的应用表明,DMI能够分别检测液体积聚、轴突损失和伤害性通路的完整性。本综述强调,与传统的扩散技术相比,DMI具有更高的灵敏度。